Drug Database
Back to search

Poland· PL-100236432

Toctino

A alitretinoin product containing alitretinoinum, registered in Poland by Stiefel Laboratoires Legacy (Ireland) Ltd..

ATC D11AX19

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedToctinoATCD11AX19REGISTER NO.PL-100236432PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alitretinoinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Alitretinoinum
Manufacturer
Stiefel Laboratoires Legacy (Ireland) Ltd.
Country
Poland (PL)
ATC code
D11AX19
ATC class
Alitretinoin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990821860

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for alitretinoin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check alitretinoin against other medicinesHow interaction checks work

Alitretinoin · interactions on record

5 records

  • 1 severe
  • 4 moderate

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • Porfimer sodiumL01XD01moderate
  • MethoxsalenL01XD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alitretinoin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alitretinoin products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Alitretan, Toctino
  • Belgium · Alitretinoin Orifarm
  • Germany · Alitrederm, Toctino
  • Denmark · Alitretinoin Orifarm, Toctino
  • Spain · Alitretinoína Ifc, Toctino
  • Finland · Alitretinoin Orifarm, Toctino
  • France · Alizem, Toctino
  • United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
  • Italy · Alitrecare, Toctino
  • Netherlands · Alipalmtin, Alitretinoïne Ifc
  • Norway · Alitretinoin Orifarm, Toctino
  • Portugal · Alitretinoína Cantabria
  • Sweden · Alitretinoin Orifarm
  • Slovenia · Toctino

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8bc4a07-77e2-4c2b-8353-227d08a7094c
GET /v1/drugs/b8bc4a07-77e2-4c2b-8353-227d08a7094c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990821860 ¦ Rp ¦ 62140\n30 kaps.",
  "substance": "Alitretinoinum do 1000 ml",
  "common_name": "Alitretinoinum",
  "pl_product_id": "100236432",
  "pozwolenie_nr": "17605",
  "auth_procedure": "MRP",
  "authorisation_validity": "2023-12-08"
}
API referenceMCP serverPlans

See everything about alitretinoin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console